Mereo Biopharma Group Stock Price History
| MREO Stock | USD 2.87 0.11 3.99% |
Below is the normalized historical share price chart for Mereo BioPharma Group extending back to April 24, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Mereo BioPharma stands at 2.87, as last reported on the 6th of July, with the highest price reaching 2.89 and the lowest price hitting 2.78 during the day.
If you're considering investing in Mereo Stock, it is important to understand the factors that can impact its price. Mereo BioPharma appears to be unstable, given 3 months investment horizon. Mereo BioPharma Group has Sharpe Ratio of 0.18, which conveys that the firm had a 0.18 % return per unit of risk over the last 3 months. By analyzing Mereo BioPharma's technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please exercise Mereo BioPharma's Risk Adjusted Performance of 0.1683, mean deviation of 3.59, and Downside Deviation of 4.53 to check out if our risk estimates are consistent with your expectations. At this time, Mereo BioPharma's Common Stock Total Equity is very stable compared to the past year. As of the 6th of July 2025, Common Stock is likely to grow to about 3.2 M, while Total Stockholder Equity is likely to drop about 45 M. . Mereo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of April 2019 | 200 Day MA 3.125 | 50 Day MA 2.5392 | Beta 0.345 |
Sharpe Ratio = 0.1843
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MREO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.47 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.82 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Mereo BioPharma is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mereo BioPharma by adding it to a well-diversified portfolio.
Price Book 7.5953 | Enterprise Value Ebitda (1.21) | Price Sales 598.1279 | Shares Float 508.7 M | Wall Street Target Price 7.6541 |
Mereo BioPharma Stock Price History Chart
There are several ways to analyze Mereo Stock price data. The simplest method is using a basic Mereo candlestick price chart, which shows Mereo BioPharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 18, 2025 | 2.87 |
| Lowest Price | April 8, 2025 | 1.76 |
Mereo BioPharma July 6, 2025 Stock Price Synopsis
Various analyses of Mereo BioPharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Mereo Stock. It can be used to describe the percentage change in the price of Mereo BioPharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Mereo Stock.| Mereo BioPharma Price Daily Balance Of Power | 1.00 | |
| Mereo BioPharma Price Action Indicator | 0.09 | |
| Mereo BioPharma Price Rate Of Daily Change | 1.04 |
Mereo BioPharma July 6, 2025 Stock Price Analysis
Mereo Stock Price History Data
The price series of Mereo BioPharma for the period between Mon, Apr 7, 2025 and Sun, Jul 6, 2025 has a statistical range of 1.11 with a coefficient of variation of 12.05. The daily prices for the period are spread out with arithmetic mean of 2.43. The median price for the last 90 days is 2.5.| Open | High | Low | Close | Volume | ||
07/06/2025 | 2.85 | 2.89 | 2.78 | 2.87 | ||
07/03/2025 | 2.85 | 2.89 | 2.78 | 2.87 | 799,203 | |
07/02/2025 | 2.76 | 2.94 | 2.71 | 2.87 | 836,557 | |
07/01/2025 | 2.71 | 2.86 | 2.66 | 2.76 | 731,590 | |
06/30/2025 | 2.68 | 2.76 | 2.63 | 2.71 | 723,034 | |
| 06/27/2025 | 2.81 | 2.81 | 2.63 | 2.66 | 1,058,505 | |
06/26/2025 | 2.78 | 2.83 | 2.69 | 2.80 | 923,563 | |
06/25/2025 | 2.74 | 2.85 | 2.68 | 2.79 | 1,019,025 | |
06/24/2025 | 2.76 | 2.81 | 2.60 | 2.72 | 2,012,072 | |
06/23/2025 | 2.84 | 2.88 | 2.72 | 2.74 | 1,407,317 | |
06/20/2025 | 2.93 | 2.94 | 2.77 | 2.85 | 1,378,950 | |
06/18/2025 | 2.80 | 2.91 | 2.78 | 2.87 | 1,107,079 | |
06/17/2025 | 2.81 | 2.82 | 2.75 | 2.80 | 1,403,119 | |
06/16/2025 | 2.79 | 2.85 | 2.73 | 2.76 | 728,746 | |
06/13/2025 | 2.77 | 2.81 | 2.72 | 2.76 | 1,235,452 | |
06/12/2025 | 2.66 | 2.85 | 2.61 | 2.78 | 1,001,180 | |
06/11/2025 | 2.67 | 2.72 | 2.64 | 2.65 | 992,062 | |
06/10/2025 | 2.67 | 2.74 | 2.65 | 2.65 | 1,307,969 | |
06/09/2025 | 2.77 | 2.77 | 2.60 | 2.65 | 1,670,383 | |
06/06/2025 | 2.50 | 2.78 | 2.49 | 2.74 | 2,194,057 | |
06/05/2025 | 2.54 | 2.61 | 2.44 | 2.46 | 1,012,726 | |
06/04/2025 | 2.65 | 2.71 | 2.55 | 2.55 | 2,891,625 | |
| 06/03/2025 | 2.56 | 2.68 | 2.51 | 2.65 | 2,148,549 | |
06/02/2025 | 2.18 | 2.56 | 2.15 | 2.55 | 1,573,575 | |
05/30/2025 | 2.21 | 2.22 | 2.11 | 2.15 | 658,257 | |
05/29/2025 | 2.21 | 2.27 | 2.19 | 2.21 | 544,457 | |
05/28/2025 | 2.19 | 2.23 | 2.12 | 2.19 | 713,980 | |
05/27/2025 | 2.25 | 2.35 | 2.15 | 2.18 | 778,260 | |
05/23/2025 | 2.25 | 2.29 | 2.20 | 2.24 | 568,851 | |
05/22/2025 | 2.26 | 2.32 | 2.22 | 2.28 | 555,008 | |
| 05/21/2025 | 2.27 | 2.33 | 2.22 | 2.24 | 972,131 | |
| 05/20/2025 | 2.29 | 2.33 | 2.22 | 2.30 | 1,056,162 | |
05/19/2025 | 2.23 | 2.29 | 2.19 | 2.29 | 1,182,325 | |
05/16/2025 | 2.18 | 2.27 | 2.12 | 2.24 | 915,495 | |
| 05/15/2025 | 2.30 | 2.30 | 2.15 | 2.18 | 951,326 | |
05/14/2025 | 2.34 | 2.36 | 2.22 | 2.31 | 923,165 | |
| 05/13/2025 | 2.50 | 2.55 | 2.26 | 2.32 | 1,715,752 | |
05/12/2025 | 2.47 | 2.55 | 2.42 | 2.50 | 1,438,098 | |
05/09/2025 | 2.45 | 2.55 | 2.38 | 2.41 | 815,944 | |
05/08/2025 | 2.40 | 2.50 | 2.29 | 2.42 | 907,929 | |
05/07/2025 | 2.47 | 2.47 | 2.28 | 2.39 | 1,189,797 | |
| 05/06/2025 | 2.53 | 2.58 | 2.33 | 2.33 | 996,423 | |
05/05/2025 | 2.63 | 2.65 | 2.54 | 2.55 | 624,735 | |
05/02/2025 | 2.62 | 2.75 | 2.60 | 2.67 | 1,349,243 | |
05/01/2025 | 2.57 | 2.65 | 2.51 | 2.60 | 774,738 | |
04/30/2025 | 2.49 | 2.60 | 2.46 | 2.59 | 806,153 | |
04/29/2025 | 2.60 | 2.65 | 2.52 | 2.52 | 375,073 | |
04/28/2025 | 2.53 | 2.64 | 2.50 | 2.61 | 1,650,484 | |
04/25/2025 | 2.52 | 2.56 | 2.38 | 2.50 | 2,329,797 | |
04/24/2025 | 2.55 | 2.58 | 2.45 | 2.54 | 2,424,525 | |
04/23/2025 | 2.57 | 2.59 | 2.49 | 2.56 | 2,611,478 | |
04/22/2025 | 2.36 | 2.55 | 2.33 | 2.50 | 2,355,875 | |
04/21/2025 | 2.30 | 2.42 | 2.26 | 2.33 | 3,567,271 | |
04/17/2025 | 2.13 | 2.34 | 2.05 | 2.30 | 2,258,433 | |
| 04/16/2025 | 1.98 | 2.15 | 1.95 | 2.13 | 1,624,932 | |
04/15/2025 | 1.89 | 2.01 | 1.89 | 2.00 | 971,886 | |
04/14/2025 | 1.96 | 1.98 | 1.84 | 1.90 | 1,957,724 | |
04/11/2025 | 1.84 | 1.98 | 1.78 | 1.95 | 1,152,461 | |
04/10/2025 | 1.91 | 1.91 | 1.71 | 1.83 | 1,050,905 | |
| 04/09/2025 | 1.70 | 1.94 | 1.58 | 1.90 | 3,504,933 | |
04/08/2025 | 1.95 | 1.99 | 1.70 | 1.76 | 3,299,548 |
About Mereo BioPharma Stock history
Mereo BioPharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mereo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mereo BioPharma Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mereo BioPharma stock prices may prove useful in developing a viable investing in Mereo BioPharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 147.9 M | 74.3 M | |
| Net Loss | -30.8 M | -32.3 M |
Mereo BioPharma Quarterly Net Working Capital |
|
Mereo BioPharma Stock Technical Analysis
Mereo BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Mereo BioPharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mereo BioPharma's price direction in advance. Along with the technical and fundamental analysis of Mereo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mereo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1683 | |||
| Jensen Alpha | 0.3507 | |||
| Total Risk Alpha | 0.1695 | |||
| Sortino Ratio | 0.0823 | |||
| Treynor Ratio | 0.3906 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mereo BioPharma Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mereo BioPharma. If investors know Mereo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mereo BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Mereo BioPharma Group is measured differently than its book value, which is the value of Mereo that is recorded on the company's balance sheet. Investors also form their own opinion of Mereo BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Mereo BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mereo BioPharma's market value can be influenced by many factors that don't directly affect Mereo BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mereo BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mereo BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mereo BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.